Astria promotes Matthews to CBO

Astria Therapeutics Inc. (NASDAQ:ATXS) promoted Andrea Matthews from SVP of corporate affairs to chief business officer. Matthews joined the company, which is developing a mAb against KLKB1 to treat hereditary angioedema, in 2014. 

Pureos Bioventures-backed TCR company Engimmune Therapeutics AG hired Lars Nieba to succeed co-founder Søren Mouritsen as CEO. Nieba was a venture partner at Pureos and previously served as CEO and CTO of Nordic Nanovector ASA (OSE:NANOV), and global head of functional excellence in clinical operations at Roche (SIX:ROG; OTCQX:RHHBY), among other roles. ...